Basic Materials / Specialty ChemicalsNSE
$312.35
-6.20 (-1.86%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-93.6M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
43/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$10.5B
P/E
318.7x
↑EV/EBITDA
18.6x
↑ROE
0.5%
↑Gross Margin
21.0%
↑Debt/Equity
0.61
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+6.8%
FCF CAGR
—
FCF margin
-0.9%
FCF / Net income
-2.83x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $10.31B · net income $33.1M · FCF $-93.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $10.31B | $10.31B | $9.28B | $8.32B | $8.46B |
| Net Income | $33.1M | $33.1M | $343.3M | $91.0M | $197.4M |
| EBITDA | $775.9M | $775.9M | $964.6M | $533.8M | $592.5M |
| EPS | 0.98 | 0.98 | 10.20 | 2.71 | 5.87 |
| Gross Margin | 21.0% | 21.0% | 25.1% | 17.5% | 18.8% |
| Operating Margin | 3.6% | 3.6% | 7.5% | 3.3% | 4.4% |
| Net Margin | 0.3% | 0.3% | 3.7% | 1.1% | 2.3% |
| Balance Sheet | |||||
| Debt/Equity | 0.61 | 0.61 | 0.53 | 0.33 | 0.37 |
| Current Ratio | 1.59 | 1.59 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-93.6M | $-93.6M | $-1.22B | $424.4M | $-690.0M |
| Returns | |||||
| ROE | 0.5% | 0.5% | 5.2% | 1.4% | 3.2% |
| Valuation | |||||
| P/E | 318.72 | 318.72 | 32.92 | 124.06 | 61.63 |
| EV/EBITDA | 18.62 | 18.62 | 15.26 | 24.85 | 24.18 |
| P/B | 1.59 | 1.59 | 1.70 | 1.79 | 1.95 |
| Growth & Yield | |||||
| Revenue Growth | 11.0% | 11.0% | 11.6% | -1.7% | — |
| EPS Growth | -90.4% | -90.4% | 276.4% | -53.8% | — |
| Dividend Yield | 0.1% | 0.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
204.7%
EPS terminal req.
$27.72
Spread vs growth
-295.1%
5Y implied EPS CAGR
102.7%
EPS terminal req.
$33.54
Spread vs growth
-193.1%
10Y implied EPS CAGR
49.3%
EPS terminal req.
$54.01
Spread vs growth
-139.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-20.6%
Start / end P/E
40.5x → 334.5x
EPS bridge
10.20 → 0.98
Residual
-655.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.